Bridgebio Pharma Inc (BBIO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BBIO? Forum Prognose

Finanzdaten der Bridgebio Pharma Inc-Aktie (BBIO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	11,999% 211.12	1.745	4.091	1.641	1.826
Cost Of Revenue	0.00% 0.598	0.598	0.598	0.599	0.651
Gross Profit	18,254% 210.52	1.147	3.493	1.042	1.175
Operating Expenses	17.71% 210.18	178.56	161.19	147.14	127.99
Interest Income/Expense	15.80% 23.47	20.27	20.31	20.59	20.12
Benefits Costs and Expenses	43.71% 247.28	172.07	183.58	162.34	144.56
Costs And Expenses	17.65% 210.78	179.16	161.78	147.74	127.99
Operating Income/Loss	100.19% 0.343	-177.42	-157.69	-146.10	-126.16
Nonoperating Income/Loss	615.00% -36.50	7.088	-21.80	-14.60	-16.57
Income/Loss From Continuing Operations Before Tax	78.77% -36.16	-170.33	-179.49	-160.70	-142.73
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	78.77% -36.16	-170.33	-179.49	-160.70	-142.73
Net Income/Loss	78.77% -36.16	-170.33	-179.49	-160.70	-142.73
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	56.70% -0.944	-2.18	-2.489	-2.804	-2.576
Basic Average Shares	4,482% 178.71	3.9004	163.31	160.54	152.65
Diluted Average Shares	4,482% 178.71	3.9004	163.31	160.54	152.65
Basic Earnings Per Share	79.17% -0.20	-0.96	-1.08	-0.98	-0.92
Diluted Earnings Per Share	79.17% -0.20	-0.96	-1.08	-0.98	-0.92
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%